Director/Executive Director of Business Development

Proclinical Consulting; Boston (KY); Remote; USD 240,000 - 390,000; Full time

Job summary

Proclinical Consulting in the United States seeks an experienced oncology business development leader to drive global licensing-out transactions and strategic partnerships for the oncology pipeline. You will lead cross-functional teams, advance transactions from term sheets to definitive agreements, and collaborate with executive management to maximize asset value. Fluency in English required; Mandarin preferred.

Qualifications

• Advanced degree in life sciences, medicine, pharmacy, oncology, biotechnology, or related field.
• PhD preferred; MBA an advantage.

Responsibilities

• Lead end-to-end global licensing-out transactions for oncology assets.
• Drive licensing discussions from term sheet to definitive agreements.
• Develop asset-specific licensing strategies based on data and market opportunities.
• Lead negotiations on upfront payments, milestones, royalties, and rights.
• Advise CBO and executives on monetization and strategy.

Skills

oncology deal-making

executive collaboration

negotiation

cross-functional leadership

global licensing

Education

Advanced degree in life sciences/related field

PhD preferred

MBA an advantage

Job description

- Permanent - Remote US Do you have the vision, influence, and deal-making expertise to shape the future of cancer therapeutics?

Proclinical is seeking an experienced oncology business development leader to drive global licensing-out transactions and strategic partnerships for the company's oncology pipeline.

Primary Responsibilities

The successful candidate will lead licensing and partnering initiatives, advancing ongoing transactions from the Term Sheet stage toward definitive licensing agreements and successful deal execution. This role requires a strong combination of oncology drug development knowledge, transaction execution expertise, commercial acumen, and senior-level partnering capabilities. The candidate will work closely with the CBO, executive management, and cross-functional teams to maximize the global commercial value of the company's oncology assets.

Skills & Requirements

• Advanced degree in life sciences, medicine, pharmacy, oncology, biotechnology, or a related field. A PhD is preferred; an MBA is an advantage.
• Proven years of relevant experience in biopharmaceutical business development, licensing, corporate development, or strategic partnering, with seniority appropriate to Director - Executive Director level.
• Strong understanding of oncology drug development, clinical trial design, competitive landscapes, and the commercial considerations relevant to oncology assets. Demonstrated experience leading or materially contributing to oncology licensing-out transactions, including term sheet negotiation, due diligence, and definitive agreement execution.
• Established relationships with pharmaceutical and biotechnology companies active in oncology development and commercialization.
• Strong knowledge of licensing economics, transaction structuring, intellectual property, clinical and regulatory milestones, and global commercialization rights.
• Proven ability to lead complex cross-border negotiations and coordinate multidisciplinary transaction teams.
• Excellent strategic thinking, negotiation, communication, and stakeholder management skills.
• Fluency in English is required; Mandarin Chinese proficiency is preferred.

The Director's Responsibilities Will Be

Oncology Licensing-out & Deal Execution

• Lead end-to-end global licensing-out transactions for oncology assets, from partner identification and initial engagement through due diligence, term sheet negotiation, definitive agreements, and deal closing.
• Drive ongoing licensing discussions and advance transactions from the Term Sheet stage toward definitive licensing agreements.
• Develop asset-specific licensing strategies based on clinical data, mechanism of action, competitive positioning, target patient populations, and market opportunities.
• Lead negotiations on upfront payments, development and regulatory milestones, royalties, territorial rights, exclusivity, intellectual property, and development and commercialization responsibilities.
• Develop transaction structures that optimize asset value while addressing commercial, clinical, regulatory, and execution risks.

Global Oncology Business Development & Partnering

• Develop and execute global licensing-out strategies for oncology pipeline assets.
• Identify and engage potential partners, including multinational pharmaceutical companies, oncology-focused biotechnology companies, and regional pharmaceutical partners.
• Build senior-level relationships with global oncology business development, licensing, and therapeutic area leadership teams.
• Evaluate partnering opportunities across relevant oncology indications, treatment modalities, and development stages.
• Represent the company in strategic partnering meetings, international oncology conferences, and senior-level licensing negotiations.

Oncology Market Intelligence & Asset Valuation

• Analyze oncology treatment landscapes, standards of care, competitive pipelines, clinical data, unmet medical needs, and commercial opportunities.
• Assess the differentiation and partnering potential of pipeline assets based on efficacy, safety, biomarker strategies, target populations, and competitive positioning.
• Develop commercial assessments and transaction valuation models in collaboration with clinical, scientific, and finance teams.
• Monitor comparable oncology licensing transactions and market trends to inform negotiation strategies and deal structures.
• Provide recommendations on asset prioritization, licensing timing, target markets, and partner selection.

Executive-level Strategic Contribution

• Advise the CBO and executive management on oncology pipeline monetization, licensing strategy, partnership opportunities, and transaction priorities.
• Lead high-level commercial negotiations with prospective partners and communicate transaction progress and risks to senior management.
• Contribute to the company's global growth strategy through strategic partnerships and value-maximizing licensing transactions.

Compensation

• $240,000 to $390,000 per annum.